Chargement en cours...
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
The majority of patients with head and neck squamous cell carcinoma (HNSCC) present with locally advanced disease, which requires site-specific combinations of surgery, radiation, and chemotherapy. Despite aggressive therapy, survival outcomes remain poor, and treatment-related morbidity is not negl...
Enregistré dans:
| Publié dans: | Onco Targets Ther |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4831599/ https://ncbi.nlm.nih.gov/pubmed/27110122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S93720 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|